Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ProKidney Corp. - Class A Ordinary Shares (NQ: PROK )

12.99 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 12.99
Bid (Size) 12.20 (3)
Ask (Size) 15.24 (1)
Prev. Close 12.99
Today's Range 12.99 - 12.99
52wk Range 5.140 - 14.19
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Friday's Intraday Session
 
Via Benzinga
Why Rivian Automotive Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) jumped 99% to $1.3195 after the company announced an agreement for the distribution of an Avian Influenza A Virus real-time PCR test kit to the... 
Via Benzinga

Performance

YTD
+89.08%
+89.08%
1 Month
+12.96%
+12.96%
3 Month
+111.22%
+111.22%
6 Month
+47.45%
+47.45%
1 Year
+50.52%
+50.52%

More News

Read More
Dick's Sporting Goods, WW International, Sea Limited And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference
From ProKidney
Via Globe NewsWire
Teradata, Monday.Com And Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Lightning eMotors Shares Are Trading Lower By 9%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
World Wrestling Entertainment, Bed Bath & Beyond And Some Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Via Benzinga
ProKidney Announces Publication of Trial Design for Phase 2 Multicenter Clinical Trial of REACT for Late Stage 4 Diabetes-Related Chronic Kidney Disease
From ProKidney
Via Globe NewsWire
CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
ProKidney Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
From ProKidney
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
ProKidney to Participate in Upcoming Investor Conferences
From ProKidney
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
Via Benzinga
ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chronic Kidney Disease
From ProKidney
Via Globe NewsWire
ProKidney Announces Multiple Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2022
From ProKidney
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
Via Benzinga
Red-Hot IPOF Stock Will Stop Trading Oct. 14. Here’s Why.
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.